XPC-8770

N/A

Report date: 2024/02/28 16:18:37

Base Information

Drug NameXPC-8770
Drug Alias NameXPC-8770
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type I alpha subunit modulators
TargetsSodium channel protein type I alpha subunit
Therapy Area/IndicationsEpilepsies, Myoclonic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXenon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesXenon Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsEpilepsies, Myoclonic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A